Clinical Trials List
2010-12-01 - 2017-12-31
Phase III
Study ended9
ICD-10E11.9
Type 2 diabetes mellitus without complications
ICD-10E13.9
Other specified diabetes mellitus without complications
ICD-9250.00
Diabetes mellitus without mention of complication, Type II [non-insulin dependent type][NIDDM type] [ adult-onset type] or unspecified type, not stated as uncontrolled
-
Trial Applicant
ELI LILLY AND COMPANY(TAIWAN), INC.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- 蔡婉妮 Division of Endocrinology
- I-TE LEE Division of Endocrinology
- 蔡易婷 Division of Endocrinology
- JUN-SING WANG Division of Endocrinology
The Actual Total Number of Participants Enrolled
0 Study ended
Co-Principal Investigator
- 郭銘俊 Division of Endocrinology
The Actual Total Number of Participants Enrolled
0 Study ended
The Actual Total Number of Participants Enrolled
0 Study ended
The Actual Total Number of Participants Enrolled
0 Study ended
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Study ended
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Study ended
Co-Principal Investigator
- 劉文華 Division of Endocrinology
The Actual Total Number of Participants Enrolled
0 Study ended
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Study ended
Co-Principal Investigator
- CHIH-YUAN WANG Division of Cardiovascular Diseases
- HUNG-JU LIN Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Study ended
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
305 participants
-
Global
9500 participants
